300357 logo

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Stock Price

SZSE:300357 Community·CN¥13.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300357 Share Price Performance

CN¥0
-22.10 (-100.00%)
CN¥0
-22.10 (-100.00%)
Price CN¥0

300357 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

1 Risk
3 Rewards

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Key Details

CN¥1.0b

Revenue

CN¥49.6m

Cost of Revenue

CN¥998.9m

Gross Profit

CN¥608.4m

Other Expenses

CN¥390.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 24, 2026
0.75
95.26%
37.24%
0.2%
View Full Analysis

About 300357

Founded
2002
Employees
1679
CEO
Jianming He
WebsiteView website
www.wolwobiotech.com

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnostic kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 and is headquartered in Huzhou, China.

Recent 300357 News & Updates

Recent updates

No updates